A few facts for you according to the folks from The Anxiety and Depression Association of America and the National Institute of Mental Health: In 2020, an estimated 14.8 million U.S. adults aged 18 or ...

Background and Objective: Escitalopram is the most selective serotonin reuptake inhibitor antidepressant; in contrast, duloxetine inhibits both serotonin and norepinephrine reuptake. Double-blind ...

Escitalopram is precribed to treat depression in adults and children ages 12 years and older, as well as generalized anxiety disorder in adults. Common side effects of escitalopram may include nausea, ...

One group received two high-dose (25 mg) treatment sessions with psilocybin, administered with support from a therapist. The other took daily doses of escitalopram (10 mg for three weeks, then 20 mg ...

This was an open, pilot study of escitalopram in patients with MDD who had not responded to treatment with citalopram (clinicaltrials.gov identifier: NCT00785434). Patients meeting the entry criteria ...

The U.S. Food and Drug Administration today approved the first generic Lexapro (escitalopram tablets) to treat both depression and generalized anxiety disorder in adults. Depression is characterized ...

Please provide your email address to receive an email when new articles are posted on . Escitalopram treatment was linked to reduced anxiety symptoms among adolescents, according to results of a ...

Adding simvastatin to escitalopram did not improve depressive symptoms in patients with major depression and obesity. Add-on simvastatin did lead to significantly greater reductions in LDL-cholesterol ...